Sinopharm: China Gives Approval For Homegrown Vaccine with Alleged 79.3% Efficacy

HNGN

31 Dec 2020 0 shares 1 views

Sinopharm: China Gives Approval For Homegrown Vaccine with Alleged 79.3% Efficacy

HNGN

Published 31 Dec 2020

The US has rolled out its Pfizer and Moderna COVID-19 vaccines, now Chinese Sinopharm has a conditional approval for its. Unlike other pharmas, this Chinese made and state owned.

Full Article

China Approves Its Homegrown COVID-19 Vaccine For Widespread Use

NPR 31 Dec 2020

The state-owned Sinopharm says its vaccine has a 79% efficacy rate — surpassing the widely accepted standard of 50% efficacy.

The Latest: China OKs 1st homegrown vaccine for coronavirus
SeattlePI.com 31 Dec 2020
China just approved its first COVID-19 vaccine as it races to inoculate the world's biggest population
Business Insider 31 Dec 2020
The Latest: Tokyo sees surge, residents urged to stay home
SeattlePI.com 31 Dec 2020
China Grants First Approval of Homegrown COVID-19 Vaccine
VOA News 31 Dec 2020

More coverage

China's first vaccine hustled to market as race to inoculate 1.3 bil speeds up
Japan Today 31 Dec 2020
China gives conditional approval to homegrown Sinopharm coronavirus vaccine
CBC.ca 31 Dec 2020

A Chinese Covid-19 Vaccine Has Proved Effective, Its Maker Says
NYTimes.com 30 Dec 2020
China to begin COVID-19 inoculations for front-line workers
SeattlePI.com 19 Dec 2020

Sinopharm: China Gives Approval For Homegrown Vaccine with Alleged 79.3% Efficacy

Sinopharm: China Gives Approval For Homegrown Vaccine with Alleged 79.3% Efficacy

You might like

Related news coverage

China Approves Its Homegrown COVID-19 Vaccine For Widespread Use

Advertisement

More coverage